Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information

FDA Lifts Pause on Chikungunya Vaccine in Older Adults, With Revised Labeling

(MedPage Today) -- The chikungunya live-attenuated vaccine (Ixchiq) can once again be used in people ages 60 and older, after the FDA reversed a recommended pause spurred by serious adverse events in vaccinated older adults. "Based on the available...

FDA Ends Suspension of Chikungunya Vaccine, Adjusts Label - The Thinking Conservative

The FDA has lifted its hold on a vaccine against chikungunya, the agency announced on Aug. 6, as it adjusted the label for the shot. The post FDA Ends Suspension of Chikungunya Vaccine, Adjusts Label appeared first on The Thinking Conservative.

FDA lifts pause on Valneva’s chikungunya shot, but adds new limits

The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new warnings and restricts vaccination to individuals at high risk of infection.

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information

Saint Herblain (France), August 7, 2025 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older and has approved updates to the Prescribing Information (PI) for IXCHIQ®. IXCHIQ® remains indicated in the United States for the prevention of disease caused by the Chikungunya Virus (CHIKV) in individuals 18 years …

Valneva Updates Safety Label of Chikungunya Virus Vaccine

Ixchiq now has a warning about its use among elderly people with multiple underlying health conditions after postmarketing reports indicated there is a risk of neurologic and cardiac events in people over the age of 60.

FDA removes hold on Valneva’s chikungunya vaccine in those over 60, adjusts product label

Valneva said the FDA has lifted a pause on the use of its chikungunya vaccine Ixchiq in older adults and also updated the product’s prescribing information. The agency no longer advises holding off on the ...